Clinical and prognostic significance of 3q26.2 and other chromosome 3 abnormalities in CML in the era of tyrosine kinase inhibitors.
暂无分享,去创建一个
T. McDonnell | H. Kantarjian | J. Cortes | P. Lin | H. Amin | Wei Wang | L. Medeiros | Shimin Hu | C. Ok | M. Beaty | D. Ai | Wei Wang